GSK’s 50 new jobs in Dungarvan

Martin Cullen T.D Minister for Social & Family Affairs unveils a plaque with Sir Christopher Gent, Chairman GlaxoSmithKline to officially open the GSK Hilo Manufacturing Facility in Dungarvan, Co.Waterford. Sean Byrne Photography.

Martin Cullen T.D Minister for Social & Family Affairs unveils a plaque with Sir Christopher Gent, Chairman GlaxoSmithKline to officially open the GSK Hilo Manufacturing Facility in Dungarvan, Co.Waterford. Sean Byrne Photography.

[View photos]

The decision by British pharmaceutical giant GlaxoSmithKline to invest €30 million in a new facility that will create 50 jobs at its plant in Dungarvan has been hailed as a further vote of confidence in the local management and staff.

Minister for Social and Family Affairs, Martin Cullen, announced details of the investment as he performed the official opening, along with GSK chairman Sir Christopher Gent, of a new €23 million facility at the Dungarvan site last Thursday.

“Implementation of these two investments, in such a short timespan, is a major vote of confidence in the Dungarvan facility and in the capabilities of the town to support such strategic developments”, said the Minister.

“The investments underpin the existing operation and its workforce and will create excellent additional employment opportunities. They will also significant enhance the facility’s role in GSK’s global business”, he added.

GSK opened its first operation in Dungarvan in 1987 and is now the largest employer in the town with 700 staff. It manufactures over-the-counter pharmaceuticals in tablet form, such as Panadol, Coldrex and Solpadeine for global markets.

The company’s second plant in the town, GSK Oral Care, was established in 2001 and is involved in the manufacture of denture care products such as Polident, Poligrip and Corega.

Michael Tyler, Vice-President and site director of GSK Dungarvan, said the latest announcement was a significant investment for the Dungarvan community and recognised the confidence and trust the company had in its employees locally.

The 50 new high-quality jobs will arrive over a three year period in the production of the smoking cessation product NiQuitin CQ, for all markets outside North America, the jobs being in production, quality, technical and engineering areas.

Mr. Tyler said the new facility will enable GSK to increase its annual tablet production in Dungarvan from 9 to 12 billion.

For full story see The Munster Express newspaper or
subscribe to our Electronic edition.

Leave a Comment